Drug Profile
DA 6650
Alternative Names: DA-6650Latest Information Update: 22 Aug 2013
Price :
$50
*
At a glance
- Originator Dong-A Pharmaceutical
- Class Anti-inflammatories; Benzamides; Irritable bowel syndrome therapies; Small molecules
- Mechanism of Action Serotonin 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Discontinued Dyspepsia; Gastro-oesophageal reflux; Irritable bowel syndrome
Most Recent Events
- 06 Nov 2011 No development reported - Phase-I for Dyspepsia in South Korea (PO)
- 06 Nov 2011 No development reported - Phase-I for Gastro-oesophageal reflux in South Korea (PO)
- 06 Nov 2011 No development reported - Phase-I for Irritable bowel syndrome in South Korea (PO)